Aspire Biopharma Holdings, Inc. (ASBP) vs VistaGen Therapeutics, Inc. (VTGN)
Aspire Biopharma Holdings, Inc. and VistaGen Therapeutics, Inc. are both Biotechnology companies. Aspire Biopharma Holdings, Inc. and VistaGen Therapeutics, Inc. are of similar size ($12.7M and $12.2M). VistaGen Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Aspire Biopharma Holdings, Inc. trades at 0.2×. VistaGen Therapeutics, Inc. has the higher net margin (−2,703.7% vs −11,309.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, VistaGen Therapeutics, Inc. leads on 10 and Aspire Biopharma Holdings, Inc. on 4.
Valuation
Profitability
| Metric | ASBP | VTGN | Biotechnology median |
|---|---|---|---|
| Gross margin | (24.97%) | 100.00% | 65.16% |
| Operating margin | (7,491.61%) | (2,785.69%) | 0.00% |
| Net margin | (11,309.31%) | (2,703.72%) | 0.00% |
| Free cash flow margin | (7,355.07%) | (2,490.88%) | 0.00% |
| Return on equity | (1,032.15%) | (166.46%) | (57.72%) |
| Return on assets | (152.09%) | (129.22%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack